A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.

Saved in:
Bibliographic Details
Title: A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine.
Authors: Dart CR; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA.; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Mukherjee N; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA., Amato CM; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Goulding A; College of Osteopathic Medicine, Western University of Health Sciences, Pomona, CA 91766, USA., MacBeth M; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Van Gulick R; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Couts KL; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Lambert JR; Department of Pathology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8104, Aurora, CO 80045, USA., Norris DA; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA.; Department of Veterans Affairs Medical Center, Dermatology Section, Denver, CO 80220, USA., Robinson WA; Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8117, Aurora, CO 80045, USA., Shellman YG; Department of Dermatology, School of Medicine, University of Colorado Anschutz Medical Campus, Mail Stop 8127, Aurora, CO 80045, USA.; Gates Center for Regenerative Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
Source: Pharmaceuticals (Basel, Switzerland) [Pharmaceuticals (Basel)] 2021 Jul 30; Vol. 14 (8). Date of Electronic Publication: 2021 Jul 30.
Publication Type: Journal Article
Journal Info: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101238453 Publication Model: Electronic Cited Medium: Print ISSN: 1424-8247 (Print) Linking ISSN: 14248247 NLM ISO Abbreviation: Pharmaceuticals (Basel) Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first